Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
The Pardee RAND Graduate School (PRGS.edu) is the largest public policy Ph.D. program in the nation and the only program based at an independent public policy research organization—the RAND Corporation.
Assistant Policy Researcher; Ph.D. Candidate, Pardee RAND Graduate School
Assistant Policy Researcher, RAND; Ph.D. Candidate, Pardee RAND Graduate School
Variations in patterns of care and treatment outcomes suggest differences in the quality of care for men treated for localized prostate cancer.
Jan 1, 2007
The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply.
Basic research is urgently needed to address measurement in populations with impaired self-report.
Jan 1, 2006
Interventions for risk-factor modification, screening, and treatment have the potential to reduce CRC mortality by almost 50% by the Year 2020.
The MISCAN-Fadia model was used to analyze the impact of screening and adjuvant treatment on U.S. breast cancer mortality between 1975 and 2000.
To evaluate the evidence of the supplements vitamin C and vitamin E for treatment and prevention of cancer.
Patterns of care after primary prostate cancer therapy continue to vary regionally.
Cause-specific mortality rates among men with prostate cancer that suggest early diagnosis and treatment for localized tumors may improve survival.
By examining the medical files of 9,672 women treated between 1990 and 2001, a newly released study by RAND researchers sought to confirm whether obese women are in fact systematically undertreated for breast cancer.
Nov 25, 2005
Systematic undertreatment of breast cancer in overweight and obese women may contribute to the poorer prognosis in these women.
Jun 1, 2005
Cancer registry data are less accurate for ambulatory-based services than hospital-based services.
Jan 1, 2005
Within a framework of quality assessment, primary treatment choice constitutes an indicator of quality of care.
To validate an Italian version of the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI).
Examines disparities in the quality of breast cancer adjuvant chemotherapy received by black and white women within a university setting.
Men with lower pretreatment quality-of-life measures may be at increased risk of fatigue after prostate cancer treatment
This commentary provides an introduction to the goals and methods of the CanCORS Consortium to cancer researchers and clinicians.
Jan 1, 2004
Geographic variation persists in patterns of care in men with early stage prostate cancer.
Concern about additional costs for direct patient care impedes efforts to enroll patients in clinical trials.
Jan 1, 2003
This study establishes a foundation on which to build quality-of-care assessment tools to evaluate the treatment of early-stage prostate cancer.
For this study, the researchers used criteria developed by the Office of Cancer Complementary and Alternative Medicine (OCCAM), a part of the National Cancer Institute.